As a physician-scientist and a board-certified medical oncologist, I am devoted to improving the lives of cancer patients. My primary clinical interest is kidney cancer. I am working with Dr. Robert Motzer on building a translational kidney cancer program to decode the molecular basis underlying treatment response and cancer metastasis. The goal of our work is to develop personalized treatment regimens for patients with kidney cancer.
I am a member of the American Society for Clinical Investigation, and my laboratory in the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center focuses on constructing the molecular blueprint of cancers and developing novel cancer therapeutics.